BIOL – biolase, inc. (US:NASDAQ)
Stock Stats
News
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
BIOLASE, Inc. (NASDAQ: BIOL) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $0.40 price target on the stock.
Biolase Reports 2024 First Quarter Results; Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability [Yahoo! Finance]
Biolase Reports 2024 First Quarter Results; Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Form 8-K BIOLASE, INC For: May 17
Form 10-Q BIOLASE, INC For: Mar 31
Form 8-K BIOLASE, INC For: May 13
Form 8-K BIOLASE, INC For: May 02
Form 424B4 BIOLASE, INC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.